Herpes zoster incidence and cost in patients receiving autologous hematopoietic stem-cell transplant

References

• Head H, Campbell AW, Kennedy PG. The pathology of Herpes Zoster and its bearing on sensory localisation. Rev Med Virol 1997;7:131-43
   PubMed Web of Science ®Google Scholar
• Gnann JW Jr, Whitley RJ. Clinical practice. Herpes zoster. N Engl J Med 2002;347:340-6
   PubMed Web of Science ®Google Scholar
• Yawn BP, Itzler RF, Wollan PC, et al. Health care utilization and cost burden of herpes zoster in a community population. Mayo Clin Proc 2009;84:787-94
   PubMed Web of Science ®Google Scholar
• Pierik JG, Gumbs PD, Fortanier SA, et al. Epidemiological characteristics and societal burden of varicella zoster virus in the Netherlands. BMC Infect Dis 2012;12:110
   PubMed Web of Science ®Google Scholar
• Insinga RP, Itzler RF, Pellissier JM, et al. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med 2005;20:748-53
   PubMed Web of Science ®Google Scholar
• Donahue JG, Choo PW, Manson JE, et al. The incidence of herpes zoster. Arch Intern Med 1995;155:1605-9
   PubMed Web of Science ®Google Scholar
• Ragozzino MW, Melton LJ, 3rd, Kurland LT, et al. Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) 1982;61:310-16
   PubMed Web of Science ®Google Scholar
• Rimland D, Moanna A. Increasing incidence of herpes zoster among Veterans. Clin Infect Dis 2010;50:1000-5
   PubMed Web of Science ®Google Scholar
• Locksley RM, Flournoy N, Sullivan KM, et al. Infection with varicella-zoster virus after marrow transplantation. J Infect Dis 1985;152:1172-81
   PubMed Web of Science ®Google Scholar
• Koc Y, Miller KB, Schenkein DP, et al. Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome. Biol Blood Marrow Transplant 2000;6:44-9
   PubMed Web of Science ®Google Scholar
• Han CS, Miller W, Haake R, et al. Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications. Bone Marrow Transplant 1994;13:277-83
   PubMed Web of Science ®Google Scholar
• Tomonari A, Iseki T, Takahashi S, et al. Varicella-zoster virus infection in adult patients after unrelated cord blood transplantation: a single institute experience in Japan. Br J Haematol 2003;122:802-5
   PubMed Web of Science ®Google Scholar
• Leung TF, Chik KW, Li CK, et al. Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation. Bone Marrow Transplant 2000;25:167-72
   PubMed Web of Science ®Google Scholar
• Arvin AM. Varicella-Zoster virus: pathogenesis, immunity, and clinical management in hematopoietic cell transplant recipients. Biol Blood Marrow Transplant 2000;6:219-30
   PubMed Web of Science ®Google Scholar
• Berman JN, Wang M, Berry W, et al. Herpes zoster infection in the post-hematopoietic stem cell transplant pediatric population may be preceded by transaminitis: an institutional experience. Bone Marrow Transplant 2006;37:73-80
   PubMed Web of Science ®Google Scholar
• Schuchter LM, Wingard JR, Piantadosi S, et al. Herpes zoster infection after autologous bone marrow transplantation. Blood 1989;74:1424-7
   PubMed Web of Science ®Google Scholar
• Rogers JE, Cumpston A, Newton M, et al. Onset and complications of varicella zoster reactivation in the autologous hematopoietic cell transplant population. Transpl Infect Dis 2011;13:480-4
   PubMed Web of Science ®Google Scholar
• Onozawa M, Hashino S, Haseyama Y, et al. Incidence and risk of postherpetic neuralgia after varicella zoster virus infection in hematopoietic cell transplantation recipients: Hokkaido Hematology Study Group. Biol Blood Marrow Transplant 2009;15:724-9
   PubMedGoogle Scholar
• Mawatari M, Isoda A, Miyazawa Y, et al. A Japanese single-hospital observational trial with a retrospective case-control analysis of varicella zoster virus reactivation after autologous peripheral blood stem cell transplantation. Transpl Infect Dis 2015;17:544-50
   PubMed Web of Science ®Google Scholar
• Drolet M, Brisson M, Levin MJ, et al. A prospective study of the herpes zoster severity of illness. Clin J Pain 2010;26:656-66
   PubMed Web of Science ®Google Scholar
• Tomblyn M, Chiller T, Einsele H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009;15:1143-238
   PubMed Web of Science ®Google Scholar
• Baden LR, Bensinger W, Angarone M, et al. Prevention and treatment of cancer-related infections. J Natl Compr Canc Netw 2012;10:1412-45
   PubMed Web of Science ®Google Scholar
• Sahoo F, Hill JA, Xie H, et al. Herpes Zoster in autologous hematopoietic cell transplant recipients in the era of acyclovir or valacyclovir prophylaxis and novel treatment and maintenance therapies. Biol Blood Marrow Transplant 2016;23:505-511
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer Network. Prevention and treatment of cancer-related infections. Version 2; Fort Washington, PA: National Comprehensive Cancer Network. 2016. Available at: https://www.nccn.org/professionals/physician_gls/PDF/infections.pdf.) [Last accessed 1 March 2017]
   Google Scholar
• Khera N, Zeliadt SB, Lee SJ. Economics of hematopoietic cell transplantation. Blood 2012;120:1545-51
   PubMed Web of Science ®Google Scholar
• Jones JA, Qazilbash MH, Shih YC, et al. In-hospital complications of autologous hematopoietic stem cell transplantation for lymphoid malignancies: clinical and economic outcomes from the Nationwide Inpatient Sample. Cancer 2008;112:1096-105
   PubMed Web of Science ®Google Scholar
• Frey P, Stinson T, Siston A, et al. Lack of caregivers limits use of outpatient hematopoietic stem cell transplant program. Bone Marrow Transplant 2002;30:741-8
   PubMed Web of Science ®Google Scholar
• Lee SJ, Klar N, Weeks JC, et al. Predicting costs of stem-cell transplantation. J Clin Oncol 2000;18:64-71
   PubMed Web of Science ®Google Scholar
• Agency for Healthcare Research and Quality. HCUP Comorbidity Software: Health Cost and Utilization Project (HCUP). Rockville, MD: Agency for Healthcare Research and Quality; 2009
   Google Scholar
• Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol 2011;173:676-82
   PubMed Web of Science ®Google Scholar
• White RR, Lenhart G, Singhal PK, et al. Incremental 1-year medical resource utilization and costs for patients with herpes zoster from a set of US health plans. Pharmacoeconomics 2009;27:781-92
   PubMed Web of Science ®Google Scholar
• Hope-Simpson RE. The nature of Herpes Zoster: a long-term study and a new hypothesis. Proc R Soc Med 1965;58:9-20
   PubMedGoogle Scholar
• Consumer Price Index. Chained Consumer Price Index for all urban consumers (C-CPI-U) 1999-2013, Medical Care. Series ID: SUUR0000SAM. US Department of Labor Bureau of Labor Statistics; 2013. Washington, DC. Available at: http://data.bls.gov/cgi-bin/surveymost?su. [Last accessed 17 March 2016]
   Google Scholar
• Boeckh M, Kim HW, Flowers ME, et al. Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation–a randomized double-blind placebo-controlled study. Blood 2006;107:1800-5
   PubMed Web of Science ®Google Scholar
• Sempere A, Sanz GF, Senent L, et al. Long-term acyclovir prophylaxis for prevention of varicella zoster virus infection after autologous blood stem cell transplantation in patients with acute leukemia. Bone Marrow Transplant 1992;10:495-8
   PubMed Web of Science ®Google Scholar
• Johnson BH, Palmer L, Gatwood J, et al. Healthcare resource utilization and costs associated with herpes zoster in the US. J Med Econ 2016;19:928-35
   PubMed Web of Science ®Google Scholar
• Li Q, Chen SY, Burstin SJ, et al. Cost of Herpes Zoster in patients with selected immune-compromised conditions in the United States. Open Forum Infect Dis 2016;3:ofw067
   PubMed Web of Science ®Google Scholar
• Majhail NS, Farnia SH, Carpenter PA, et al. Indications for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant 2015;21:1863-9
   PubMed Web of Science ®Google Scholar
• Center for International Blood & Marrow Transplant Research. Summary slides- HCT trends and survival data. Milwaukee, WI: Center for International Blood & Marrow Transplant Research; 2015
   Google Scholar
• Yawn BP, Wollan P, St Sauver J. Comparing shingles incidence and complication rates from medical record review and administrative database estimates: how close are they? Am J Epidemiol 2011;174:1054-61.
   PubMed Web of Science ®Google Scholar
• Yawn BP, Saddier P, Wollan PC, et al. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 2007;82:1341-9
   PubMed Web of Science ®Google Scholar